Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Exicure, Inc. - Common Stock
(NQ:
XCUR
)
4.900
-1.840 (-27.30%)
Streaming Delayed Price
Updated: 3:59 PM EST, Dec 5, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Exicure, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
12 Health Care Stocks Moving In Friday's After-Market Session
↗
October 24, 2025
Via
Benzinga
Halper Sadeh LLC Encourages Exicure, Inc. Shareholders to Contact the Firm to Discuss Their Rights
October 22, 2025
From
Halper Sadeh LLC
Via
Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
September 11, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
September 11, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
August 11, 2025
Via
Benzinga
Exicure Posts Wider Loss in Fiscal Q2
↗
August 08, 2025
Via
The Motley Fool
Topics
Intellectual Property
Exicure, Inc. Reports Second Quarter 2025 Financial Results
August 08, 2025
From
Exicure, Inc.
Via
Business Wire
Exicure, Inc. (Nasdaq: XCUR) Regains Compliance with Nasdaq Filing Requirements
August 04, 2025
From
Exicure, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
↗
August 01, 2025
Via
Benzinga
What's going on in today's after hours session
↗
August 01, 2025
The regular session of the US market on Friday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Via
Chartmill
Exicure Completes the Last Patient, Last Visit in Phase 2 Study of GPC-100 for Stem Cell Mobilization in Multiple Myeloma Patients Undergoing Autologous Transplant
August 01, 2025
From
Exicure, Inc.
Via
Business Wire
Which stocks have an unusual volume on Thursday?
↗
July 03, 2025
The trading volume of these stocks is deviating from the norm in today's session.
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
July 01, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
July 01, 2025
Via
Benzinga
Progress Software, Exicure And 3 Stocks To Watch Heading Into Monday
↗
June 30, 2025
U.S. stock futures up, focus on PRGS, XCUR, QMCO earnings. VERO jumps 43.6% after stake increase, IGC reports positive results. Check out Cramer's oil pick. Photo: Shutterstock.
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
↗
June 27, 2025
Via
Benzinga
Exicure, Inc. Reports First Quarter 2025 Financial Results
June 27, 2025
From
Exicure, Inc.
Via
Business Wire
Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q
May 28, 2025
From
Exicure, Inc.
Via
Business Wire
Exicure Completes Patient Enrollment in Phase 2 Study of GPC-100 for Stem Cell Mobilization in Multiple Myeloma Patients Undergoing Autologous Transplant
May 05, 2025
From
Exicure, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's Intraday Session
↗
April 21, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
April 17, 2025
Via
Benzinga
Exicure, Inc. (Nasdaq: XCUR) Nears Completion of Phase 2 Study of GPC-100 in Multiple Myeloma
April 14, 2025
From
Exicure, Inc.
Via
Business Wire
Exicure, Inc. (Nasdaq: XCUR) Announces Their Next Step in Planning for a New Clinical Trial in Acute Myeloid Leukemia (AML)
April 11, 2025
From
Exicure, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
March 18, 2025
Via
Benzinga
Exicure, Inc. Reports Full Year 2024 Financial Results
March 18, 2025
From
Exicure, Inc.
Via
Business Wire
Exicure, Inc. (Nasdaq: XCUR) Announces Issuance of New Patent in Australia
March 13, 2025
From
Exicure, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
March 13, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
February 07, 2025
Via
Benzinga
Exicure Stock Soars Over 25% On Acquisition Of GPCR Therapeutics’ U.S. Unit: Retail Chatter Spikes
↗
January 23, 2025
GPCR USA is noted for its work in developing cutting-edge treatments, including Opdivo, a widely used autoimmune disease therapy generating about $10 billion in annual revenue.
Via
Stocktwits
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
January 23, 2025
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today